Why 2026 will force a fundamental rethink of biopharma commercialization What commercialization looks like when headcount shrinks, launches can’t miss, and geography becomes a risk decision.

https://www.drugdiscoverynews.com/why-2026-will-force-a-fundamental-rethink-of-biopharma-commercialization-16971